|
|
Kenya
|
H2020/CTD7980/16504
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM) , LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
Botswana
|
BOT2600177
|
DOLUTEGRAVIR (AS SODIUM) LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50/300/300 MG
|
Dolutegravir Sodium 52.620mg
|
Cipla Limited, Goa (Unit-VII)
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695A
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695B
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Botswana
|
BOT2103695C
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE USP & TENOFOVIR DISOPROXIL FUMARATE
|
-
|
SUN PHARMACEUTICAL INDUSTRIES LTD
|
Registered/Compliant
|
Details →
|
|
|
Rwanda
|
Rwanda FDA-HMP-MA-0048
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE, TENOFOVIR DISOPROXIL
|
Dolutegravir (As Sodium), Lamivudine, Tenofovir Disoproxil Fumarate
|
CIPLA LIMITED
|
Registered
|
Details →
|
|
|
Kenya
|
H2022/CTD9776/21543
|
DOLUTEGRAVIR TABLETS 50 MG
|
DOLUTEGRAVIR (AS SODIUM)
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
Kenya
|
H2025/CTD12306/26376
|
ABACAVIR (AS SULFATE), DOLUTEGRAVIR (AS SODIUM) AND LAMIVUDINE 60 MG/ 5 MG/ 30 MG DISPERSIBLE TABLETS
|
ABACAVIR SULFATE USP DOLUTEGRAVIR SODIUM LAMIVUDINE USP
|
PHILLIPS HEALTHCARE SERVICES LTD
|
Registered
|
Details →
|
|
|
Zambia
|
ZAMRA-HM-25-181
|
Abacavir (as Sulfate), Dolutegravir (as Sodium) and Lamivudine 60 mg/ 5 mg/ 30 mg Dispersible tablets
|
Abacavir (as Sulfate), Dolutegravir (as Sodium) and Lamivudine 60 mg/ 5 mg/ 30 mg Dispersible tablets
|
Cipla Limited
|
Registered/Compliant
|
Details →
|
|
|
Tanzania
|
TAN 24 HM 0375
|
Abacavir (as Sulfate), Dolutegravir (as Sodium) and Lamivudine
|
Abacavir Sulfate 60 mg/6 mL,Aspartame 3.500 mg/6 mL,Aspartame 6.000 mg/6 mL,Calcium sulphate dihydrate. 2.000 mg/6 mL,Colloidal Silicon Dioxide 0.400 mg/6 mL,Colloidal Silicon Dioxide 1.250 mg/6 mL,Crospovidone (Kollidon CL-SF) 10.000 mg/6 mL,Crospovidone (Kollidon CL-SF) 4.000 mg/6 mL,Dolutegravir Sodium 5 mg/6 mL,Ferric Oxide Red / Red Oxide of Iron 0.020 mg/6 mL,Lamivudine 30 mg/6 mL,Magnesium Stearate (Vegetable Grade) (with surface area) 0.800 mg/6 mL,Magnesium Stearate (Vegetable Grade) (with surface area) 2.650 mg/6 mL,Mannitol (Pearlitol 50 C) 14.500 mg/6 mL,Microcrystalline Cellulose (Avicel PH 101) 4.720 mg/6 mL,Microcrystalline Cellulose (MCC for DC) (Avicel PH 102) 15.000 mg/6 mL,Microcrystalline Cellulose (MCC for DC) (Avicel PH 102) 37.580 mg/6 mL,Microcrystalline Cellulose (MCC for DC) (Avicel PH 102) 46.538 mg/6 mL,Opadry II 85F240128 Pink 8.000 mg/6 mL,Povidone (PVP K30) 1.000 mg/6 mL,Povidone (PVP K30) 1.500 mg/6 mL,Povidone (PVPK – 30) 1.000 mg/6 mL,Purified Water q.s. ml,Sodium Starch Gl
|
CIPLA LTD. INDORE(UNIT IV)
|
Registered/Compliant
|
Details →
|
|
|
Kenya
|
H2022/CTD9938/22681
|
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 50 MG/ 300 MG/ 300 MG
|
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE
|
SAI PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
Rwanda
|
RWANDA-FDA24/HM/0863/0119
|
Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 50 mg / 300 mg / 300 mg
|
Dolutegravir (as sodium), Lamivudine and Tenofovir Disoproxil Fumarate
|
LUPIN MANUFACTURING SOLUTIONS LIMITED
|
Registered
|
Details →
|
|
|
Nigeria
|
Dolutegravir (as Sodium)/ Lamivudine/Tenofovir Disoproxil Fumarate 50 mg/300 mg/300 mg Tablets
|
Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate
|
Drugs
|
Oral
|
Registered
|
Details →
|